when bruschi suffered a stroke in 2005, he was treated at massachusetts general hospital, which he said was well equipped to handle the medical emergency..

the report was compiled by outside researchers who went into the fda�s own database of �serious adverse [medical-drug] events.�...

following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)..